Cardium Therapeutics, Inc. (CXM) Announces Receipt of $1.1 Million in Funds from Philips' Acquisition of INNERCOOL Therapies
8/18/2011 11:14:28 AM
More...
|
Cardium Therapeutics, Inc. (CXM) Completes Sale of INNERCOOL Therapies Business to Royal Phillips Electronics
7/24/2009 8:00:38 AM
More...
|
Cardium Therapeutics, Inc. (CXM)'s INNERCOOL Therapies Announces Journal of Neurotrauma Highlights Hypothermia Therapy's Role in Post Cardiac Arrest, and Traumatic Brain and Spinal Cord Injury Patients
3/31/2009 9:34:05 AM
More...
|
Cardium Therapeutics, Inc. (CXM)'s INNERCOOL Therapies Announces Launch of New Enhanced Website
1/27/2009 10:21:04 AM
More...
|
Cardium Therapeutics, Inc. (CXM) and INNERCOOL Therapies Complete $5 Million Commercial Financing to Support Launch of New Product Lines
11/15/2007 9:23:39 AM
More...
|
INNERCOOL Therapies Licenses New Therapeutic for Potential Use in Stroke Patients
10/22/2007 9:22:20 AM
More...
|
INNERCOOL Therapies Launches CoolBlue Patient Temperature Modulation System
10/18/2007 7:44:12 AM
More...
|
Cardium Therapeutics, Inc. (CDTP.OB) and INNERCOOL Therapies: Newsweek Cover Story Examines Benefits of Lowering Body Temperature in Cardiac Arrest Victims
7/17/2007 11:44:02 AM
More...
|
Cardium Therapeutics, Inc. (CDTP.OB): INNERCOOL Therapies to Present Next-Generation Patient Temperature Modulation Systems at New York Neurological Symposium
5/16/2007 12:43:14 PM
More...
|
Cardium Therapeutics, Inc. (CDTP.OB): First Patient Enrolled in RAPID MI-ICE Study Employing INNERCOOL Therapies's Endovascular Temperature Modulation Therapy for Heart Attack
3/22/2007 12:17:56 PM
More...
|
|